Inspire Veterinary Partners Faces Delisting Notice
Ticker: IVPR · Form: 8-K · Filed: Sep 30, 2024 · CIK: 1939365
| Field | Detail |
|---|---|
| Company | Inspire Veterinary Partners, Inc. (IVPR) |
| Form Type | 8-K |
| Filed Date | Sep 30, 2024 |
| Risk Level | high |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
TL;DR
IVP got a delisting warning, stock might be toast.
AI Summary
Inspire Veterinary Partners, Inc. filed an 8-K on September 30, 2024, reporting a notice of delisting or failure to satisfy continued listing rules as of September 24, 2024. The company, incorporated in Nevada, is involved in agriculture services.
Why It Matters
This filing indicates potential delisting from a stock exchange, which could significantly impact the liquidity and valuation of the company's shares.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's continued trading on an exchange.
Key Players & Entities
- INSPIRE VETERINARY PARTNERS, INC. (company) — Registrant
- September 24, 2024 (date) — Earliest event date
- September 30, 2024 (date) — Filing date
- Nevada (jurisdiction) — State of incorporation
- 001-41792 (identifier) — Commission File Number
- 85-4359258 (identifier) — IRS Employer Identification No.
- 780 Lynnhaven Parkway , Suite 400 Virginia Beach , VA 23452 (address) — Principal executive offices
- ( 757 ) 734-5464 (phone_number) — Registrant's telephone number
FAQ
What is the specific reason for the notice of delisting or failure to satisfy continued listing rules?
The filing does not specify the exact reason for the delisting notice, only that it is a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing'.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on September 24, 2024.
What is the company's state of incorporation?
The company is incorporated in Nevada.
What is the company's principal executive office address?
The principal executive offices are located at 780 Lynnhaven Parkway, Suite 400, Virginia Beach, VA 23452.
What is the Commission File Number for Inspire Veterinary Partners, Inc.?
The Commission File Number is 001-41792.
Filing Stats: 559 words · 2 min read · ~2 pages · Grade level 12.4 · Accepted 2024-09-30 16:24:37
Key Financial Figures
- $0.0001 — ch registered Common stock, par value $0.0001 IVP Nasdaq Capital Market Indicat
Filing Documents
- ea0216189-8k_inspire.htm (8-K) — 26KB
- 0001213900-24-083381.txt ( ) — 197KB
- ivp-20240924.xsd (EX-101.SCH) — 3KB
- ivp-20240924_lab.xml (EX-101.LAB) — 33KB
- ivp-20240924_pre.xml (EX-101.PRE) — 22KB
- ea0216189-8k_inspire_htm.xml (XML) — 4KB
01 Notice of Delisting or Failure
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 24, 2024, Inspire Veterinary Partners, Inc. (the "Company") received a staff determination letter from the Listing Qualifications Staff (the "Staff") of The Nasdaq Stock Market ("Nasdaq") notifying the Company that, based on its review of the Company's securities, the Staff determined that the Company failed to comply with Nasdaq's shareholder approval requirements set forth in Listing Rule 5635(d). The Staff stated that the Company's "best efforts" public offering, which closed on July 15, 2024, did not qualify as a public offering for the purposes of Nasdaq's shareholder approval rules. As such, Listing Rule 5635(d ),which requires prior shareholder approval for transactions other than public offerings involving the issuance of 20% or more of the pre-transaction shares outstanding at less than the Minimum Price was not met. Accordingly, this matter serves as an additional basis for delisting the Company's securities from Nasdaq. The Company will present its views with respect to this additional deficiency to the Nasdaq Hearings Panel (the "Panel") in writing no later than October 1, 2024. The Company's securities will not be suspended or delisted while the Panel makes its determination regarding the Company's continued listing on Nasdaq. 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 30, 2024 INSPIRE VETERINARY PARTNERS, INC. By: /s/ Kimball Carr Name: Kimball Carr Title: President and Chief Executive Officer 2